A 35-year-old woman from rural Maharashtra presents to the gynaecology clinic with postcoital bleeding and vaginal discharge for 3 months. On examination, a friable cervical mass is noted. Pap smear shows atypical squamous cells of undetermined significance (ASCUS). What is the most appropriate next step in management?

Explanation

## Clinical Context The patient presents with clinical signs suggestive of cervical malignancy (friable cervical mass, postcoital bleeding). The Pap smear shows ASCUS, which carries a 5–10% risk of underlying cervical intraepithelial neoplasia (CIN) 2/3 or cancer. ## Management Algorithm for ASCUS with Clinical Suspicion ```mermaid flowchart TD A[Pap smear: ASCUS]:::outcome --> B{Clinical signs of malignancy?}:::decision B -->|Yes: friable mass, bleeding| C[Colposcopy with biopsy]:::action B -->|No: asymptomatic| D[HPV reflex test or repeat cytology]:::action C --> E[Tissue diagnosis + staging]:::outcome D --> F{HPV positive or repeat ASCUS?}:::decision F -->|Yes| G[Colposcopy]:::action F -->|No| H[Routine screening]:::action ``` ## Why Colposcopy with Biopsy is Correct **Key Point:** When ASCUS is accompanied by clinical signs of cervical malignancy (friable mass, postcoital bleeding, vaginal discharge), colposcopy with direct cervical biopsy is mandatory to exclude invasive disease. Cytology alone is insufficient when malignancy is clinically suspected. **High-Yield:** The presence of a visible cervical lesion on examination automatically escalates the triage pathway from cytology-based algorithms to direct tissue diagnosis. This is a critical clinical principle that overrides the standard ASCUS management algorithm. **Clinical Pearl:** Friability, bleeding, and mass formation are red flags for CIN 3 or invasive squamous cell carcinoma. Delaying biopsy risks upstaging and worsening prognosis. ## Supporting Evidence [cite:Robbins 10e Ch 22] emphasizes that any visible cervical abnormality warrants immediate colposcopic evaluation regardless of cytology results. Indian guidelines (ICMR) similarly recommend direct colposcopy when clinical suspicion is high. ## Differential Management Pathways | Scenario | Next Step | Rationale | |----------|-----------|----------| | ASCUS + visible cervical lesion | Colposcopy + biopsy | Rule out invasive disease | | ASCUS + no clinical signs | HPV reflex or repeat cytology | Low immediate cancer risk | | ASCUS + HPV positive | Colposcopy | Elevated CIN risk | | ASCUS + HPV negative | Routine screening | Very low cancer risk |